| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipid transporter activity | 1.10e-06 | 196 | 107 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.23e-05 | 9 | 107 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.18e-05 | 12 | 107 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | transporter activity | ANO4 SLC12A6 ANO2 CEACAM5 ABCA12 CEACAM6 BCL2 SLC7A14 CEACAM1 STARD5 SLC12A4 TSPO2 CNGB3 TSPO SLC2A13 SLC12A7 ATP2A3 ANO3 SCN3B | 5.02e-05 | 1289 | 107 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.22e-05 | 14 | 107 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.75e-05 | 125 | 107 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 8.50e-05 | 3 | 107 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.15e-04 | 18 | 107 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.23e-04 | 90 | 107 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 1.60e-04 | 20 | 107 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 1.60e-04 | 20 | 107 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.60e-04 | 51 | 107 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.63e-04 | 151 | 107 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 1.69e-04 | 4 | 107 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 SLC12A6 ANO2 CEACAM5 ABCA12 CEACAM6 BCL2 SLC7A14 CEACAM1 SLC12A4 TSPO2 CNGB3 SLC2A13 SLC12A7 ATP2A3 ANO3 SCN3B | 1.73e-04 | 1180 | 107 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.45e-04 | 23 | 107 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 2.45e-04 | 23 | 107 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.45e-04 | 23 | 107 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | cholesterol binding | 2.65e-04 | 58 | 107 | 4 | GO:0015485 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.81e-04 | 5 | 107 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.20e-04 | 171 | 107 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.56e-04 | 26 | 107 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 4.21e-04 | 6 | 107 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | ferroxidase activity | 4.21e-04 | 6 | 107 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 4.21e-04 | 6 | 107 | 2 | GO:0016724 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.45e-04 | 28 | 107 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | filamin binding | 4.94e-04 | 29 | 107 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.94e-04 | 29 | 107 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.44e-04 | 70 | 107 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | sterol binding | 5.75e-04 | 71 | 107 | 4 | GO:0032934 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.38e-04 | 73 | 107 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | 5'-deoxyribose-5-phosphate lyase activity | 7.80e-04 | 8 | 107 | 2 | GO:0051575 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 7.93e-04 | 34 | 107 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 8.64e-04 | 35 | 107 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.02e-03 | 37 | 107 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.25e-03 | 149 | 107 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.41e-03 | 310 | 107 | 7 | GO:0030246 | |
| GeneOntologyMolecularFunction | channel activity | 2.06e-03 | 525 | 107 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.08e-03 | 526 | 107 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.21e-03 | 102 | 107 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.30e-03 | 49 | 107 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.44e-03 | 50 | 107 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.86e-03 | 119 | 107 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 4.12e-03 | 18 | 107 | 2 | GO:0016722 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.16e-03 | 207 | 107 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.27e-03 | 208 | 107 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | AMP binding | 5.59e-03 | 21 | 107 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.59e-03 | 211 | 107 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | steroid binding | 5.72e-03 | 133 | 107 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.75e-03 | 614 | 107 | 9 | GO:0140657 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 5.26e-07 | 4 | 106 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | CEACAM5 ABCA12 CEACAM6 GRM2 CEACAM1 STARD5 ADIPOQ TSPO2 OSBPL6 TSPO SLC2A13 | 2.36e-06 | 358 | 106 | 11 | GO:0015850 |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.69e-06 | 21 | 106 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.69e-06 | 21 | 106 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | chloride transport | 4.40e-06 | 128 | 106 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.49e-06 | 22 | 106 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.40e-05 | 33 | 106 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.46e-05 | 112 | 106 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | lipid localization | ANO4 CEACAM5 ABCA12 CEACAM6 CEACAM1 STARD5 ADIPOQ TSPO2 ANGPTL3 OSBPL6 TSPO ANO3 | 3.36e-05 | 565 | 106 | 12 | GO:0010876 |
| GeneOntologyBiologicalProcess | glucan catabolic process | 3.42e-05 | 36 | 106 | 4 | GO:0009251 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 3.63e-05 | 13 | 106 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.04e-05 | 180 | 106 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 4.25e-05 | 38 | 106 | 4 | GO:0000272 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 4.49e-05 | 183 | 106 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.61e-05 | 14 | 106 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 5.74e-05 | 15 | 106 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 5.74e-05 | 15 | 106 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 5.74e-05 | 15 | 106 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.74e-05 | 15 | 106 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | lipid transport | ANO4 CEACAM5 ABCA12 CEACAM6 CEACAM1 STARD5 ADIPOQ TSPO2 OSBPL6 TSPO ANO3 | 5.92e-05 | 506 | 106 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | cholesterol transport | 6.73e-05 | 134 | 106 | 6 | GO:0030301 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 6.73e-05 | 134 | 106 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 7.04e-05 | 16 | 106 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | sterol transport | 8.25e-05 | 139 | 106 | 6 | GO:0015918 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 8.51e-05 | 17 | 106 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.51e-05 | 17 | 106 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 8.51e-05 | 17 | 106 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 8.62e-05 | 87 | 106 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.02e-04 | 18 | 106 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.17e-04 | 49 | 106 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of anoikis | 1.20e-04 | 19 | 106 | 3 | GO:2000811 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.27e-04 | 50 | 106 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.40e-04 | 153 | 106 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.41e-04 | 20 | 106 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.64e-04 | 21 | 106 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 1.75e-04 | 101 | 106 | 5 | GO:0044042 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.97e-04 | 56 | 106 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC12A6 ABCA12 JPH2 CP BCL2 GRM2 ADIPOQ SLC12A4 PDE8B ANGPTL3 PKHD1 TSPO PYGL PYGM HEPHL1 SLC12A7 ATP2A3 | 2.06e-04 | 1249 | 106 | 17 | GO:0048878 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.17e-04 | 23 | 106 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.17e-04 | 23 | 106 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.47e-04 | 24 | 106 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.47e-04 | 24 | 106 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.47e-04 | 24 | 106 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.58e-04 | 60 | 106 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 2.59e-04 | 5 | 106 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 2.59e-04 | 5 | 106 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 2.59e-04 | 5 | 106 | 2 | GO:0061591 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.75e-04 | 61 | 106 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.79e-04 | 25 | 106 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.79e-04 | 25 | 106 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 2.79e-04 | 25 | 106 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | regulation of anoikis | 3.15e-04 | 26 | 106 | 3 | GO:2000209 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 3.26e-04 | 252 | 106 | 7 | GO:0022408 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 3.53e-04 | 27 | 106 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial depolarization | 3.53e-04 | 27 | 106 | 3 | GO:0051900 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.94e-04 | 28 | 106 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 3.94e-04 | 28 | 106 | 3 | GO:0055081 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 4.37e-04 | 29 | 106 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 4.52e-04 | 124 | 106 | 5 | GO:0050672 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 4.86e-04 | 126 | 106 | 5 | GO:0032945 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 4.86e-04 | 126 | 106 | 5 | GO:0005976 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | ADCY10 MGAM CD244 MAN1C1 NAGA PHKA2 ADIPOQ ANGPTL3 PYGL PYGM CHID1 | 4.91e-04 | 646 | 106 | 11 | GO:0005975 |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.91e-04 | 71 | 106 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 5.16e-04 | 449 | 106 | 9 | GO:0002449 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 5.34e-04 | 31 | 106 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.87e-04 | 32 | 106 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.87e-04 | 32 | 106 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.87e-04 | 32 | 106 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.43e-04 | 33 | 106 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 6.44e-04 | 134 | 106 | 5 | GO:0070664 | |
| GeneOntologyBiologicalProcess | glomerulus development | 6.69e-04 | 77 | 106 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.03e-04 | 34 | 106 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.03e-04 | 34 | 106 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 7.10e-04 | 375 | 106 | 8 | GO:0007162 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 7.66e-04 | 35 | 106 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | mitochondrial depolarization | 7.66e-04 | 35 | 106 | 3 | GO:0051882 | |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 7.66e-04 | 35 | 106 | 3 | GO:0005980 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | CEACAM5 ABL2 CD244 ABCA12 CEACAM6 CEACAM1 PBRM1 ADIPOQ PKHD1 IL4I1 | 8.11e-04 | 580 | 106 | 10 | GO:0022407 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 8.87e-04 | 83 | 106 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 8.87e-04 | 83 | 106 | 4 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 8.87e-04 | 83 | 106 | 4 | GO:0032371 | |
| GeneOntologyBiologicalProcess | anoikis | 9.03e-04 | 37 | 106 | 3 | GO:0043276 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 9.03e-04 | 37 | 106 | 3 | GO:0055075 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 9.35e-04 | 301 | 106 | 7 | GO:0050670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 9.69e-04 | 85 | 106 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 9.76e-04 | 38 | 106 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 1.03e-03 | 306 | 106 | 7 | GO:0032944 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 1.04e-03 | 149 | 106 | 5 | GO:0062014 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.05e-03 | 39 | 106 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.10e-03 | 151 | 106 | 5 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.14e-03 | 40 | 106 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.22e-03 | 41 | 106 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 1.22e-03 | 41 | 106 | 3 | GO:0070286 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CEACAM5 ABL2 ERF CD244 NRCAM ABCA12 CEACAM6 BCL2 ITGB4 CEACAM1 PBRM1 ADIPOQ PKHD1 IL4I1 | 1.23e-03 | 1077 | 106 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | CEACAM5 ABL2 CD244 EXOSC3 CEACAM6 BCL2 CEACAM1 PBRM1 BTK IL4I1 | 1.25e-03 | 614 | 106 | 10 | GO:0051249 |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.25e-03 | 91 | 106 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.27e-03 | 232 | 106 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.31e-03 | 42 | 106 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 1.31e-03 | 42 | 106 | 3 | GO:0006884 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 JPH2 CP BCL2 SLC12A4 PKHD1 PYGM HEPHL1 SLC12A7 ATP2A3 | 1.37e-03 | 622 | 106 | 10 | GO:0098771 |
| GeneOntologyCellularComponent | cilium | ADCY10 ANO2 CEACAM5 CEACAM6 DNAH7 CEACAM1 NEK4 RSPH10B2 DNAH17 CNGB3 PKHD1 CFAP44 DNAH5 IL4I1 WDR49 RSPH10B | 2.09e-05 | 898 | 111 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 7.76e-05 | 16 | 111 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.08e-04 | 25 | 111 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | astrocyte projection | 3.08e-04 | 25 | 111 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ANGPT2 ITGB4 MFAP4 ADIPOQ ANGPTL2 FCN1 SPON1 ANGPTL3 CTSS ZG16 | 5.27e-04 | 530 | 111 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | motile cilium | 6.19e-04 | 355 | 111 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | extracellular matrix | ANGPT2 ITGB4 MFAP4 ADIPOQ ANGPTL2 FCN1 SPON1 ANGPTL3 MMP17 CTSS ZG16 | 7.38e-04 | 656 | 111 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ANGPT2 ITGB4 MFAP4 ADIPOQ ANGPTL2 FCN1 SPON1 ANGPTL3 MMP17 CTSS ZG16 | 7.57e-04 | 658 | 111 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | apical plasma membrane | ADCY10 SLC12A6 MGAM CEACAM5 PDZK1P1 CEACAM6 CEACAM1 PKHD1 SLC2A13 | 1.16e-03 | 487 | 111 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.71e-03 | 238 | 111 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.78e-03 | 12 | 111 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 1.78e-03 | 12 | 111 | 2 | GO:0097450 | |
| GeneOntologyCellularComponent | glial cell projection | 1.99e-03 | 47 | 111 | 3 | GO:0097386 | |
| GeneOntologyCellularComponent | cell surface | CEACAM5 CD244 NRCAM CEACAM3 CEACAM6 CP ITGB4 CEACAM1 ADIPOQ FCN1 CD163L1 ANGPTL3 PKHD1 CTSS | 2.26e-03 | 1111 | 111 | 14 | GO:0009986 |
| MousePheno | increased abdominal fat pad weight | 2.30e-05 | 27 | 88 | 4 | MP:0009286 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.99e-07 | 24 | 105 | 5 | IPR014715 | |
| Domain | - | 1.99e-07 | 24 | 105 | 5 | 4.10.530.10 | |
| Domain | Fibrinogen_C | 3.73e-07 | 27 | 105 | 5 | PF00147 | |
| Domain | FBG | 5.44e-07 | 29 | 105 | 5 | SM00186 | |
| Domain | Kelch_2 | 6.49e-07 | 13 | 105 | 4 | IPR011498 | |
| Domain | Kelch_2 | 6.49e-07 | 13 | 105 | 4 | PF07646 | |
| Domain | - | 6.50e-07 | 30 | 105 | 5 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 6.50e-07 | 30 | 105 | 5 | IPR014716 | |
| Domain | KCL_cotranspt | 6.88e-07 | 4 | 105 | 3 | IPR000076 | |
| Domain | FIBRINOGEN_C_1 | 9.11e-07 | 32 | 105 | 5 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 9.11e-07 | 32 | 105 | 5 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 9.11e-07 | 32 | 105 | 5 | PS51406 | |
| Domain | Anoct_dimer | 5.94e-06 | 7 | 105 | 3 | PF16178 | |
| Domain | Anoct_dimer | 5.94e-06 | 7 | 105 | 3 | IPR032394 | |
| Domain | SLC12A_fam | 5.94e-06 | 7 | 105 | 3 | IPR004842 | |
| Domain | AA-permease/SLC12A_dom | 6.38e-06 | 22 | 105 | 4 | IPR004841 | |
| Domain | AA_permease | 6.38e-06 | 22 | 105 | 4 | PF00324 | |
| Domain | SLC12_C | 9.47e-06 | 8 | 105 | 3 | IPR018491 | |
| Domain | Chond_GalNAc | 9.47e-06 | 8 | 105 | 3 | IPR008428 | |
| Domain | CHGN | 9.47e-06 | 8 | 105 | 3 | PF05679 | |
| Domain | SLC12 | 9.47e-06 | 8 | 105 | 3 | PF03522 | |
| Domain | Anoctamin | 2.01e-05 | 10 | 105 | 3 | PF04547 | |
| Domain | Anoctamin | 2.01e-05 | 10 | 105 | 3 | IPR007632 | |
| Domain | TspO_MBR | 3.13e-05 | 2 | 105 | 2 | PF03073 | |
| Domain | TspO_MBR | 3.13e-05 | 2 | 105 | 2 | IPR004307 | |
| Domain | KCC1 | 3.13e-05 | 2 | 105 | 2 | IPR000622 | |
| Domain | MORN | 6.01e-05 | 14 | 105 | 3 | SM00698 | |
| Domain | MORN | 7.48e-05 | 15 | 105 | 3 | IPR003409 | |
| Domain | MORN | 7.48e-05 | 15 | 105 | 3 | PF02493 | |
| Domain | PHOSPHORYLASE | 9.36e-05 | 3 | 105 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 9.36e-05 | 3 | 105 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 9.36e-05 | 3 | 105 | 2 | IPR000811 | |
| Domain | MULTICOPPER_OXIDASE2 | 9.36e-05 | 3 | 105 | 2 | PS00080 | |
| Domain | Phosphorylase | 9.36e-05 | 3 | 105 | 2 | PF00343 | |
| Domain | Fibrinogen_CS | 1.57e-04 | 19 | 105 | 3 | IPR020837 | |
| Domain | Cu-oxidase_2 | 1.86e-04 | 4 | 105 | 2 | IPR011706 | |
| Domain | Cu-oxidase_2 | 1.86e-04 | 4 | 105 | 2 | PF07731 | |
| Domain | Cu-oxidase_3 | 3.10e-04 | 5 | 105 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 3.10e-04 | 5 | 105 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 3.10e-04 | 5 | 105 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 3.10e-04 | 5 | 105 | 2 | PF07732 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.38e-04 | 59 | 105 | 4 | IPR011043 | |
| Domain | Cu_oxidase_Cu_BS | 4.63e-04 | 6 | 105 | 2 | IPR002355 | |
| Domain | V-set | 6.05e-04 | 184 | 105 | 6 | PF07686 | |
| Domain | Kelch_1 | 6.50e-04 | 70 | 105 | 4 | PF01344 | |
| Domain | Kelch_1 | 6.50e-04 | 70 | 105 | 4 | IPR006652 | |
| Domain | Ig_2 | 7.62e-04 | 73 | 105 | 4 | PF13895 | |
| Domain | Ig_V-set | 9.11e-04 | 199 | 105 | 6 | IPR013106 | |
| Domain | IG | 2.59e-03 | 421 | 105 | 8 | SM00409 | |
| Domain | Ig_sub | 2.59e-03 | 421 | 105 | 8 | IPR003599 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.73e-03 | 14 | 105 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.73e-03 | 14 | 105 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.73e-03 | 14 | 105 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.73e-03 | 14 | 105 | 2 | PF08393 | |
| Domain | - | 2.73e-03 | 14 | 105 | 2 | 2.60.40.420 | |
| Domain | MT | 2.73e-03 | 14 | 105 | 2 | PF12777 | |
| Domain | AAA_8 | 2.73e-03 | 14 | 105 | 2 | PF12780 | |
| Domain | DHC_fam | 3.13e-03 | 15 | 105 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.13e-03 | 15 | 105 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.13e-03 | 15 | 105 | 2 | IPR004273 | |
| Domain | Glycoside_hydrolase_SF | 3.30e-03 | 53 | 105 | 3 | IPR017853 | |
| Domain | Kelch-typ_b-propeller | 3.66e-03 | 55 | 105 | 3 | IPR015915 | |
| Domain | - | CEACAM5 CD244 NRCAM CEACAM3 CEACAM6 ITGB4 CEACAM1 PKHD1 CNTN3 SCN3B | 4.14e-03 | 663 | 105 | 10 | 2.60.40.10 |
| Domain | WD40_repeat | 4.37e-03 | 272 | 105 | 6 | IPR001680 | |
| Domain | Ig_I-set | 4.39e-03 | 190 | 105 | 5 | IPR013098 | |
| Domain | I-set | 4.39e-03 | 190 | 105 | 5 | PF07679 | |
| Domain | ig | 4.39e-03 | 190 | 105 | 5 | PF00047 | |
| Domain | Immunoglobulin | 4.39e-03 | 190 | 105 | 5 | IPR013151 | |
| Domain | WD_REPEATS_1 | 4.85e-03 | 278 | 105 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.94e-03 | 279 | 105 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.94e-03 | 279 | 105 | 6 | PS50294 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 7.28e-06 | 7 | 85 | 3 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 7.28e-06 | 7 | 85 | 3 | MM15081 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 5.79e-05 | 13 | 85 | 3 | M46426 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 7.34e-05 | 14 | 85 | 3 | M19193 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 7.34e-05 | 14 | 85 | 3 | MM15391 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.62e-04 | 18 | 85 | 3 | MM15577 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.67e-04 | 194 | 85 | 7 | M16312 | |
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 9.83e-11 | 4 | 111 | 4 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 9.83e-11 | 4 | 111 | 4 | 27748756 | |
| Pubmed | HGFAC NRCAM CP ITGB4 CEACAM1 MFAP4 ENTPD5 ANGPTL3 CNTN3 C1R C5 | 7.15e-10 | 257 | 111 | 11 | 16335952 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 5.57e-09 | 77 | 111 | 7 | 16944957 | |
| Pubmed | Signal peptide prediction based on analysis of experimentally verified cleavage sites. | HGFAC CD244 CEACAM6 MFAP4 ADIPOQ FCN1 CD163L1 ANGPTL3 IL4I1 ZG16 | 1.41e-08 | 264 | 111 | 10 | 15340161 |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 34847408 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 25409014 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 11551954 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 15262997 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 22064717 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 3.16e-08 | 3 | 111 | 3 | 21733850 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 31171910 | ||
| Pubmed | 9.60e-08 | 14 | 111 | 4 | 1648219 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 26483485 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10436421 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 12739008 | ||
| Pubmed | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. | 1.26e-07 | 4 | 111 | 3 | 19077207 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 12637262 | ||
| Pubmed | 1.31e-07 | 15 | 111 | 4 | 25490771 | ||
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 6.28e-07 | 6 | 111 | 3 | 15067359 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 1.75e-06 | 8 | 111 | 3 | 21613606 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 1.75e-06 | 8 | 111 | 3 | 24393035 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 12386165 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 19323993 | ||
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 3.74e-06 | 10 | 111 | 3 | 23532839 | |
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 3.74e-06 | 10 | 111 | 3 | 19015192 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 24692353 | ||
| Pubmed | 6.09e-06 | 513 | 111 | 10 | 25798074 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 6.14e-06 | 303 | 111 | 8 | 25056061 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.84e-06 | 13 | 111 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.84e-06 | 13 | 111 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.84e-06 | 13 | 111 | 3 | 16638824 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 20044046 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 32150576 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 6265583 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.84e-06 | 13 | 111 | 3 | 12832451 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.84e-06 | 13 | 111 | 3 | 21670291 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 22162753 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 2702644 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 8380065 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 1279194 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 25724769 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.84e-06 | 13 | 111 | 3 | 22092845 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 11801635 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.84e-06 | 13 | 111 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.84e-06 | 13 | 111 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.84e-06 | 13 | 111 | 3 | 23800882 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 19285068 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 21760897 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 8.84e-06 | 13 | 111 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 8.84e-06 | 13 | 111 | 3 | 39168268 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 8402684 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 16619040 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 8.84e-06 | 13 | 111 | 3 | 8209741 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 8.84e-06 | 13 | 111 | 3 | 21949477 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 26219866 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 2133556 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 32521208 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 19406938 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 8.84e-06 | 13 | 111 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 8.84e-06 | 13 | 111 | 3 | 19358828 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 16680193 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.84e-06 | 13 | 111 | 3 | 34058224 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 10964771 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 32169849 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.84e-06 | 13 | 111 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.84e-06 | 13 | 111 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.84e-06 | 13 | 111 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.84e-06 | 13 | 111 | 3 | 23935487 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 15331748 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.84e-06 | 13 | 111 | 3 | 22406619 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.84e-06 | 13 | 111 | 3 | 25972571 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 19008452 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.84e-06 | 13 | 111 | 3 | 15220458 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 18843289 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 15207636 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 21081647 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 11133662 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 11483763 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 2164599 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 29396368 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 18003729 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 8.84e-06 | 13 | 111 | 3 | 33352461 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 38381498 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 20739537 | ||
| Interaction | CEACAM1 interactions | 4.51e-06 | 21 | 109 | 4 | int:CEACAM1 | |
| Interaction | CEACAM7 interactions | 5.30e-06 | 7 | 109 | 3 | int:CEACAM7 | |
| Cytoband | 15q13 | 2.06e-04 | 9 | 111 | 2 | 15q13 | |
| Cytoband | 7p22.1 | 2.06e-04 | 47 | 111 | 3 | 7p22.1 | |
| Cytoband | 15q26 | 6.80e-04 | 16 | 111 | 2 | 15q26 | |
| Cytoband | 19q13.2 | 6.98e-04 | 164 | 111 | 4 | 19q13.2 | |
| Cytoband | 14q21.3 | 1.95e-03 | 27 | 111 | 2 | 14q21.3 | |
| Cytoband | 12p13.3 | 2.41e-03 | 30 | 111 | 2 | 12p13.3 | |
| GeneFamily | Fibrinogen C domain containing | 7.89e-08 | 25 | 81 | 5 | 554 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 3.71e-06 | 24 | 81 | 4 | 906 | |
| GeneFamily | Anoctamins | 1.02e-05 | 10 | 81 | 3 | 865 | |
| GeneFamily | Dyneins, axonemal | 5.63e-05 | 17 | 81 | 3 | 536 | |
| GeneFamily | Beta 4-glycosyltransferases | 5.63e-05 | 17 | 81 | 3 | 425 | |
| GeneFamily | Glycogen phosphorylases | 5.93e-05 | 3 | 81 | 2 | 437 | |
| GeneFamily | Immunoglobulin like domain containing | 2.29e-04 | 193 | 81 | 6 | 594 | |
| GeneFamily | Fibrinogen C domain containing|Angiopoietin like | 5.45e-04 | 8 | 81 | 2 | 905 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.26e-04 | 163 | 81 | 5 | 590 | |
| GeneFamily | DNA polymerases | 4.72e-03 | 23 | 81 | 2 | 535 | |
| GeneFamily | Beta 3-glycosyltransferases | 5.13e-03 | 24 | 81 | 2 | 426 | |
| GeneFamily | WD repeat domain containing | 6.44e-03 | 262 | 81 | 5 | 362 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.48e-03 | 394 | 81 | 6 | 471 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 5.19e-06 | 301 | 110 | 9 | M45708 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.39e-05 | 35 | 110 | 4 | MM757 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-09 | 198 | 111 | 9 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-09 | 198 | 111 | 9 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-08 | 184 | 111 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-08 | 184 | 111 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-08 | 184 | 111 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.66e-08 | 198 | 111 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.66e-08 | 198 | 111 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.66e-08 | 198 | 111 | 8 | 66d65951a6a39cc5d5ba5f96fdf3eb61c74ac616 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.80e-08 | 199 | 111 | 8 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.80e-08 | 199 | 111 | 8 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.95e-08 | 200 | 111 | 8 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.95e-08 | 200 | 111 | 8 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-07 | 176 | 111 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-07 | 176 | 111 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.62e-07 | 181 | 111 | 7 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-07 | 182 | 111 | 7 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-07 | 182 | 111 | 7 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 4.36e-07 | 186 | 111 | 7 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.85e-07 | 189 | 111 | 7 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-07 | 189 | 111 | 7 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.21e-07 | 191 | 111 | 7 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-07 | 191 | 111 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.21e-07 | 191 | 111 | 7 | 7065728128e37572b87e6b024374796bd2172e92 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.21e-07 | 191 | 111 | 7 | 7717cf1d99b4451d7145d91367637895f9a2c1c3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-07 | 192 | 111 | 7 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 5.39e-07 | 192 | 111 | 7 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 192 | 111 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 192 | 111 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 192 | 111 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-07 | 194 | 111 | 7 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-07 | 194 | 111 | 7 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.99e-07 | 195 | 111 | 7 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.99e-07 | 195 | 111 | 7 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 5.99e-07 | 195 | 111 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-07 | 198 | 111 | 7 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.63e-07 | 198 | 111 | 7 | 103e8267e57a9027aeccd0762c1508272d214a32 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.86e-07 | 199 | 111 | 7 | 7cbd98dd10c91584dee04593910031e90c1340b8 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.86e-07 | 199 | 111 | 7 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.09e-07 | 200 | 111 | 7 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 153 | 111 | 6 | 83942ef63d21725fa15ed5a91481d1f9936e8f11 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 165 | 111 | 6 | ce79d217df88035457cd58f679e72dd98722ae22 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 3.79e-06 | 166 | 111 | 6 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 168 | 111 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 168 | 111 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 169 | 111 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 169 | 111 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.49e-06 | 171 | 111 | 6 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-06 | 173 | 111 | 6 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-06 | 173 | 111 | 6 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 4.80e-06 | 173 | 111 | 6 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-06 | 176 | 111 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 5.48e-06 | 177 | 111 | 6 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 5.66e-06 | 178 | 111 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 5.66e-06 | 178 | 111 | 6 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 182 | 111 | 6 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-06 | 183 | 111 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.84e-06 | 184 | 111 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.84e-06 | 184 | 111 | 6 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Myelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.05e-06 | 185 | 111 | 6 | 92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 7.05e-06 | 185 | 111 | 6 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-06 | 185 | 111 | 6 | 97f8a644f51c02a5f8a74d8c923ad637a15ed06d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-06 | 186 | 111 | 6 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Myelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.27e-06 | 186 | 111 | 6 | 53b4ce33ae6fa32f1b56cbc62b1d7915e935afc9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-06 | 186 | 111 | 6 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 186 | 111 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 187 | 111 | 6 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 188 | 111 | 6 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.73e-06 | 188 | 111 | 6 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-06 | 189 | 111 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.21e-06 | 190 | 111 | 6 | cb62ece5929896dfba30a4f563c6ba5a5712b71e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.21e-06 | 190 | 111 | 6 | fedd266198d294d8da8c9e217e5e0cb8b2e1b566 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-06 | 190 | 111 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.21e-06 | 190 | 111 | 6 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.21e-06 | 190 | 111 | 6 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.21e-06 | 190 | 111 | 6 | 5da4a90f56f66567614d84b9b437f559006ea51c | |
| ToppCell | COVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class | 8.21e-06 | 190 | 111 | 6 | 8a81cb90273c361e9fdfaa0a31806da253fa1388 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.46e-06 | 191 | 111 | 6 | 78ede1f15484414a2a54a2f0f0cb6abe0c6b6513 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.46e-06 | 191 | 111 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 191 | 111 | 6 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.46e-06 | 191 | 111 | 6 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.46e-06 | 191 | 111 | 6 | d049ab9abd5f8d497eb7e3ccb39b28283298bc65 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.72e-06 | 192 | 111 | 6 | 0ba5729a890bfba5db567cd0eec7924cd1991ac3 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.72e-06 | 192 | 111 | 6 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-06 | 192 | 111 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.98e-06 | 193 | 111 | 6 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.98e-06 | 193 | 111 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 193 | 111 | 6 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.25e-06 | 194 | 111 | 6 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 9.25e-06 | 194 | 111 | 6 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.52e-06 | 195 | 111 | 6 | b0dbaae86f5703ab62f925e0f36500274044884a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.52e-06 | 195 | 111 | 6 | d07a8cfecf7a54cf6274565b1649e735abb79c87 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.52e-06 | 195 | 111 | 6 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.80e-06 | 196 | 111 | 6 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.80e-06 | 196 | 111 | 6 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| Drug | 3'-chloromethotrexate | 4.25e-07 | 4 | 109 | 3 | CID000097703 | |
| Drug | butylethanolamine | 8.65e-07 | 16 | 109 | 4 | CID000249006 | |
| Drug | zinc glycinate | 1.44e-06 | 18 | 109 | 4 | CID000151910 | |
| Drug | Potassium Chloride | 2.11e-06 | 6 | 109 | 3 | DB00761 | |
| Drug | AC1L3XPY | 2.79e-06 | 21 | 109 | 4 | CID000124005 | |
| Drug | formycins | 3.68e-06 | 7 | 109 | 3 | CID000512867 | |
| Drug | heptenitol | 3.68e-06 | 7 | 109 | 3 | CID000188267 | |
| Drug | GDP-Man | 5.05e-06 | 140 | 109 | 7 | CID000000732 | |
| Drug | 1,2-dideoxy-d-arabino-hex-1-enopyranose | 5.82e-06 | 25 | 109 | 4 | CID000089465 | |
| Drug | AC1NUVX5 | 5.87e-06 | 8 | 109 | 3 | CID005461894 | |
| Drug | monomethyl phthalate | SLC12A6 MGAM ERF ANGPT2 AOX1 NAGA CP ARAF ALDH1A2 PBRM1 SLC12A4 FCN1 BTK POLL MMP17 CTSS | 1.28e-05 | 957 | 109 | 16 | ctd:C517284 |
| Drug | glucosyl fluoride | 1.71e-05 | 11 | 109 | 3 | CID000150967 | |
| Drug | 9 Da | 1.71e-05 | 11 | 109 | 3 | CID005287565 | |
| Drug | ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C095651 | |
| Drug | 1-N-Acetyl-Beta-D-Glucosamine | 2.27e-05 | 2 | 109 | 2 | DB02320 | |
| Drug | 2-deoxyguanosine | 2.42e-05 | 178 | 109 | 7 | CID000000638 | |
| Drug | nojirimycin | 3.24e-05 | 38 | 109 | 4 | CID000065242 | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 3.67e-05 | 190 | 109 | 7 | 3733_UP | |
| Drug | JH I | 3.74e-05 | 14 | 109 | 3 | CID005365101 | |
| Drug | maltoheptose | 3.98e-05 | 40 | 109 | 4 | CID003037125 | |
| Drug | AC1L1IZE | 4.03e-05 | 131 | 109 | 6 | CID000004799 | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 4069_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; HL60; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 3069_UP | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 7265_UP | |
| Drug | 4-nitrophenylmaltoheptaoside | 4.66e-05 | 15 | 109 | 3 | CID000173254 | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 4142_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 4101_UP | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 5015_UP | |
| Drug | AC1NDP1R | 4.84e-05 | 42 | 109 | 4 | CID004629338 | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 7030_DN | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; PC3; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 6294_UP | |
| Drug | AC1L1IPV | 5.31e-05 | 43 | 109 | 4 | CID000004683 | |
| Drug | Bumetanide | 5.71e-05 | 16 | 109 | 3 | ctd:D002034 | |
| Drug | periodic acid | 5.94e-05 | 205 | 109 | 7 | CID000065185 | |
| Drug | 3,5-dimethylphenyl isocyanate | 6.79e-05 | 3 | 109 | 2 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 6.79e-05 | 3 | 109 | 2 | CID000147839 | |
| Drug | NSC758405 | 6.79e-05 | 3 | 109 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 6.79e-05 | 3 | 109 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 6.79e-05 | 3 | 109 | 2 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 6.79e-05 | 3 | 109 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 6.79e-05 | 3 | 109 | 2 | CID000191554 | |
| Drug | hydan | 6.79e-05 | 3 | 109 | 2 | CID000008360 | |
| Drug | EHMF | 6.79e-05 | 3 | 109 | 2 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 6.79e-05 | 3 | 109 | 2 | CID003082249 | |
| Drug | Plp 5'-mpa | 6.79e-05 | 3 | 109 | 2 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 6.79e-05 | 3 | 109 | 2 | CID000191723 | |
| Drug | 3'-FFdUrd | 6.79e-05 | 3 | 109 | 2 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 6.79e-05 | 3 | 109 | 2 | CID000119518 | |
| Drug | AC1L8XK3 | 6.79e-05 | 3 | 109 | 2 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 6.79e-05 | 3 | 109 | 2 | CID000446801 | |
| Drug | Rodorubicine | 6.79e-05 | 3 | 109 | 2 | CID000057097 | |
| Drug | riboflavin tetraacetate | 6.79e-05 | 3 | 109 | 2 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 6.79e-05 | 3 | 109 | 2 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 6.79e-05 | 3 | 109 | 2 | CID000011459 | |
| Drug | homonojirimycin | 6.91e-05 | 17 | 109 | 3 | CID000159496 | |
| Drug | fagomine | 6.91e-05 | 17 | 109 | 3 | CID000072259 | |
| Drug | acarbose | 8.97e-05 | 94 | 109 | 5 | CID000041774 | |
| Drug | pyridoxal 5'-phosphate | 1.02e-04 | 301 | 109 | 8 | CID000001051 | |
| Drug | NSC633770 | 1.04e-04 | 51 | 109 | 4 | CID000003183 | |
| Drug | amylopectin | 1.13e-04 | 52 | 109 | 4 | CID000439207 | |
| Drug | I0329 | 1.33e-04 | 21 | 109 | 3 | CID000439668 | |
| Drug | galocitabine | 1.35e-04 | 4 | 109 | 2 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 1.35e-04 | 4 | 109 | 2 | CID000135786 | |
| Drug | ingliforib | 1.35e-04 | 4 | 109 | 2 | CID006451325 | |
| Drug | uric acid riboside | 1.35e-04 | 4 | 109 | 2 | CID000164933 | |
| Drug | BCLF-2 | 1.35e-04 | 4 | 109 | 2 | CID000139814 | |
| Drug | pseudo-dl-glucose | 1.35e-04 | 4 | 109 | 2 | CID000125259 | |
| Drug | pyridoxal diphosphate | 1.35e-04 | 4 | 109 | 2 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.35e-04 | 4 | 109 | 2 | CID000189134 | |
| Drug | AC1LAMW2 | 1.35e-04 | 4 | 109 | 2 | CID000491364 | |
| Drug | FdUrd-C8 | 1.35e-04 | 4 | 109 | 2 | CID000094262 | |
| Drug | Mem-CC | 1.35e-04 | 4 | 109 | 2 | CID003081269 | |
| Drug | AC1L9JSY | 1.35e-04 | 4 | 109 | 2 | CID000446552 | |
| Drug | dichloroacetonitrile | 1.35e-04 | 4 | 109 | 2 | ctd:C051716 | |
| Drug | BCIp4A | 1.35e-04 | 4 | 109 | 2 | CID000192417 | |
| Drug | maltosaccharide | 1.54e-04 | 22 | 109 | 3 | CID005461034 | |
| Drug | 5-fluorodeoxyuridine | 1.58e-04 | 106 | 109 | 5 | CID000003363 | |
| Drug | AC1L9R2Z | 1.60e-04 | 168 | 109 | 6 | CID000453624 | |
| Drug | 4-pyridoxic acid | 1.76e-04 | 23 | 109 | 3 | CID000006723 | |
| Drug | ginsenoside | 1.76e-04 | 23 | 109 | 3 | CID000092797 | |
| Drug | AC1L9IMU | 1.76e-04 | 23 | 109 | 3 | CID000445825 | |
| Drug | dicyclohexyl phthalate | SLC12A6 MGAM ANGPT2 AOX1 NAGA CP ALDH1A2 PBRM1 SLC12A4 FCN1 BTK MMP17 CTSS | 1.82e-04 | 836 | 109 | 13 | ctd:C036042 |
| Drug | sanguinarine | 1.97e-04 | 60 | 109 | 4 | CID000005154 | |
| Drug | BrVarafUTP | 2.01e-04 | 24 | 109 | 3 | CID005273539 | |
| Drug | heptulose-2-P | 2.25e-04 | 5 | 109 | 2 | CID000124823 | |
| Drug | 6-FPLP | 2.25e-04 | 5 | 109 | 2 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.25e-04 | 5 | 109 | 2 | CID009576855 | |
| Drug | DHPBU | 2.25e-04 | 5 | 109 | 2 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 2.25e-04 | 5 | 109 | 2 | CID003080910 | |
| Drug | AC1LAW6Y | 2.25e-04 | 5 | 109 | 2 | CID000521877 | |
| Drug | indirubin-5-sulphonate | 2.25e-04 | 5 | 109 | 2 | CID005288641 | |
| Drug | AC1NQPMN | 2.25e-04 | 5 | 109 | 2 | CID005276919 | |
| Drug | AC1LCUXJ | 2.25e-04 | 5 | 109 | 2 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 2.25e-04 | 5 | 109 | 2 | CID000080578 | |
| Drug | 1H-indazole-3-carboxylic acid | 2.25e-04 | 5 | 109 | 2 | CID000078250 | |
| Drug | etafenone | 2.25e-04 | 5 | 109 | 2 | CID000003275 | |
| Drug | ddEtUrd | 2.25e-04 | 5 | 109 | 2 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 2.25e-04 | 5 | 109 | 2 | CID000125618 | |
| Drug | Trichlormethiazide | 2.25e-04 | 5 | 109 | 2 | ctd:D014237 | |
| Drug | m-anisidine | 2.25e-04 | 5 | 109 | 2 | CID000010824 | |
| Disease | Glycogen Storage Disease | 1.10e-04 | 27 | 102 | 3 | C0017919 | |
| Disease | Alzheimer disease | 2.86e-04 | 485 | 102 | 8 | MONDO_0004975 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.89e-04 | 41 | 102 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.89e-04 | 41 | 102 | 3 | C0858252 | |
| Disease | response to simvastatin, PCSK9 protein measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0006899, GO_1903491 | |
| Disease | glycogen storage disease (is_implicated_in) | 4.19e-04 | 9 | 102 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (biomarker_via_orthology) | 5.23e-04 | 10 | 102 | 2 | DOID:11984 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 5.67e-04 | 109 | 102 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 5.67e-04 | 109 | 102 | 4 | C0000786 | |
| Disease | Miscarriage | 5.67e-04 | 109 | 102 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 5.67e-04 | 109 | 102 | 4 | C0000822 | |
| Disease | glycerophospholipid measurement | 6.58e-04 | 49 | 102 | 3 | EFO_0007630 | |
| Disease | triglycerides in LDL measurement | 9.73e-04 | 56 | 102 | 3 | EFO_0022320 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.05e-03 | 14 | 102 | 2 | EFO_0020941 | |
| Disease | idiopathic dilated cardiomyopathy | 1.19e-03 | 60 | 102 | 3 | EFO_0009094 | |
| Disease | BMI-adjusted adiponectin measurement | 1.21e-03 | 15 | 102 | 2 | EFO_0007737 | |
| Disease | triglycerides in small VLDL measurement | 1.25e-03 | 61 | 102 | 3 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 1.31e-03 | 62 | 102 | 3 | EFO_0022158 | |
| Disease | triglycerides in medium LDL measurement | 1.31e-03 | 62 | 102 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.31e-03 | 62 | 102 | 3 | EFO_0022339 | |
| Disease | triglycerides in small LDL measurement | 1.50e-03 | 65 | 102 | 3 | EFO_0022323 | |
| Disease | Glycogen storage disease | 1.56e-03 | 17 | 102 | 2 | cv:C0017919 | |
| Disease | triglycerides in very small VLDL measurement | 1.71e-03 | 68 | 102 | 3 | EFO_0022144 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.95e-03 | 19 | 102 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | serum carcinoembryonic antigen measurement | 2.16e-03 | 20 | 102 | 2 | EFO_0005760 | |
| Disease | Retinal Degeneration | 2.38e-03 | 21 | 102 | 2 | C0035304 | |
| Disease | epilepsy (implicated_via_orthology) | 2.51e-03 | 163 | 102 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 3.04e-03 | 702 | 102 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVWFGTFYYAALKGV | 146 | Q96ND0 | |
| EYQGVIAWQGDYGEF | 56 | A0A1W2PQ73 | |
| EYQGVIAWQGDYGEF | 41 | P50548 | |
| GGQYGEVYVGVWKKY | 296 | P42684 | |
| GQFGVVKYGKWRGQY | 411 | Q06187 | |
| GYWEVNGFGLLGIYK | 921 | Q6L9W6 | |
| QGVIKTFRYYAGWAD | 141 | O94788 | |
| VWLQVYGEGERNGLY | 211 | Q15848 | |
| NEFVQKRYGGWSFGL | 1891 | Q86UK0 | |
| HLFGYSWYKGERVDG | 61 | P06731 | |
| YRYQKVGYWAEGLTL | 466 | Q14416 | |
| EYKVGFGNPSGEYWL | 341 | O15123 | |
| YKQGFGNIDGEYWLG | 336 | Q9UKU9 | |
| GNIDGEYWLGLENIY | 341 | Q9UKU9 | |
| NYKYGFGRLDGEFWL | 301 | Q9Y5C1 | |
| KGVADSGPLYQYWGR | 451 | Q96PN6 | |
| FGEKIGLYFAWLGLY | 356 | Q9NQ90 | |
| RYFGEKIGLYFAWLG | 341 | Q32M45 | |
| YGRLEVKYQGEWGTV | 486 | Q9NR16 | |
| AYLGWKKARQEGGYR | 1141 | Q7Z478 | |
| QKGEEYRVTGYGGWS | 1021 | Q12830 | |
| WGIGCSRGYGFYTKV | 676 | P00736 | |
| KFWVSLGGYDSGFLY | 761 | Q96MT7 | |
| GSWLRGAVYYFKIAV | 286 | Q93084 | |
| GWLFFRYLAIGVYVG | 831 | Q93084 | |
| LYFGEKIGLYFAWLG | 386 | Q9BYT9 | |
| WEKGEGQPFEYFVYG | 1151 | Q06278 | |
| AYSVQGDKWRALGYA | 266 | Q9UGP5 | |
| FGIGYNTRWKEDIRY | 316 | Q6P1R3 | |
| YGDIWTLHDGGFRNY | 696 | Q6ZMN7 | |
| LGYHVVTFDYRGWGD | 196 | Q8N2K0 | |
| HGIYFSGNTYLWRGE | 656 | P00450 | |
| QGTYIWADGLKYEGD | 121 | P0C881 | |
| WGIRCYKSGNIYEGQ | 216 | P0C881 | |
| QGTYIWADGLKYEGD | 121 | B2RC85 | |
| WGIRCYKSGNIYEGQ | 216 | B2RC85 | |
| KVWVRDGAAYFYGPI | 1181 | Q86U86 | |
| GRIYILGGYSWENTA | 546 | Q8N4N3 | |
| RAYLVGGWNEGEKKY | 566 | Q9H511 | |
| LYKGEWTHGFKGRYG | 81 | Q9BR39 | |
| WIFGGVKYQYGGNQE | 281 | O75356 | |
| FYVEYGVAGSKEEWR | 1096 | Q92823 | |
| GWEEARDFDGKVYYI | 11 | Q8IX03 | |
| ITAEGELYTWGRGNY | 566 | O95714 | |
| VTAAGDLYTWGKGRY | 4106 | O95714 | |
| GAVYTWGKGDYHRLG | 4216 | O95714 | |
| NRIGYSWYKGERVDG | 61 | P40199 | |
| YYTGVDINARGEWKT | 2581 | O43451 | |
| YGFYLRAGSEQKGWG | 131 | A8MUH7 | |
| WQGVYYARRKSGDSI | 341 | O95263 | |
| VTYKESWEGGDGLLY | 66 | P51957 | |
| KNGVAYLYGIISWGD | 606 | Q04756 | |
| GKGLEWIGYIYYSGS | 61 | P01825 | |
| GYRVKYWIQGDSESE | 1156 | P16144 | |
| YRLFGKWHEGLYCGV | 791 | Q9BZF3 | |
| VDFYRDWAAYKQGFG | 166 | O00602 | |
| WLGISYKGIGQYDIQ | 271 | Q9Y2L6 | |
| VKNLGYRDSGYYWEV | 291 | P10398 | |
| YKYLDESSGGWRDGR | 51 | O00115 | |
| GSYVYGLFMEGARWD | 4371 | Q9UFH2 | |
| LGIYEHGYGNWELIK | 1271 | O14647 | |
| QLFGYSWYKGERVDG | 61 | P13688 | |
| VGLAVCWGGRDAYYF | 1901 | O75417 | |
| IKWLSEEQRYGGGFY | 1271 | P01031 | |
| EYIARAGWTPEGKYA | 376 | Q6V1X1 | |
| WVGYEKEGFRGHQYL | 1216 | Q8N1P7 | |
| VEADIGNYWRGLYKL | 796 | Q8WXX0 | |
| HLFGYSWYKGERVDG | 61 | P40198 | |
| YFTQGDNRIGGKYWK | 416 | Q6MZM0 | |
| GGLGDSFYEYLIKSW | 386 | Q9NR34 | |
| DGNFLYVWGGYVSIE | 21 | Q8N7A1 | |
| VWGGYKSNQVRGLYD | 46 | Q9Y2U9 | |
| LVVGYGDLNGKEYWL | 281 | P25774 | |
| GDYEILYWDVAGGCK | 746 | Q32P44 | |
| WLEYGQYSVGGIGQK | 186 | Q15020 | |
| YIEYQGAEKEWGDGI | 716 | Q9UHW9 | |
| YIEYRGAEKEWGDGI | 651 | Q9Y666 | |
| RDGNVSYAWYRGSKL | 161 | Q9BZW8 | |
| GGGVYWVDSQQKRYV | 96 | Q9NQT5 | |
| GVSLLYIGWDKHYGF | 131 | P25789 | |
| GVSIWELGQGLDYFY | 376 | Q9BWS9 | |
| LGYEVRYWNGGGKEE | 836 | Q9P232 | |
| EGVYVYGLYLEGAGW | 4531 | Q8TE73 | |
| YGKAGLNQEWGLIRY | 811 | P46019 | |
| IYEGDWKFGKRDGYG | 61 | Q6PF18 | |
| KDDWTVPYGRIYFAG | 466 | Q96RQ9 | |
| VDGAFSYLQKDGWRY | 226 | Q96QE2 | |
| WEYGGYASEGVKQVA | 246 | Q9HCB6 | |
| DWRHYVGKEYFRALG | 341 | Q9NUP7 | |
| AAAFIYEKRGGTYWA | 101 | Q96HP8 | |
| YFFRGQEYWKVLDGE | 491 | Q9ULZ9 | |
| DEWVLKGISGYIYGL | 366 | Q6P1X5 | |
| WNDYKLGFGRADGEY | 96 | P55083 | |
| DGLWYHIGVIGYNKA | 1641 | P08F94 | |
| YIEYQGAEKEWGDGI | 651 | Q9UP95 | |
| YKLSQRGYEWDAGDV | 21 | P10415 | |
| GFWRNYGFGITCIYK | 686 | Q86X52 | |
| KTGFWRDYGYGITCI | 771 | Q70JA7 | |
| NYEGIGTTRWVYDGE | 376 | Q9NQW8 | |
| GTTRWVYDGEGNEYL | 381 | Q9NQW8 | |
| AGLFFINGKYWAEGQ | 231 | Q8TBB6 | |
| HYTEGERGWGREKFY | 1036 | Q9H9J4 | |
| AFFLGAERGYSWYKG | 316 | Q9NUD5 | |
| RYEFGIFNQKISGGW | 161 | P11217 | |
| FGAERWDNLIYYALG | 171 | Q15269 | |
| RLVTGGYDYDVKFWD | 196 | Q9NW82 | |
| VLWIKGAQGGDYFYS | 81 | Q9BYN0 | |
| YRGEGIVYGTLEEVW | 51 | Q9NSY2 | |
| GGSGYVRFWDIYKKQ | 396 | Q8IV35 | |
| LTERFWESYIYNGKG | 86 | O14669 | |
| WESYIYNGKGGRGRV | 91 | O14669 | |
| EWFYRPEGGKDFLIY | 61 | Q9NY72 | |
| SRGLLYKGVYEGWYC | 156 | Q96GW9 | |
| VRYGKVWSDYVGGRN | 66 | O60844 | |
| VVGYASYLVWKDLGG | 56 | Q5TGU0 | |
| RYEYGIFNQKIRDGW | 161 | P06737 | |
| GYGSYLVWKELGGFT | 61 | P30536 | |
| GYTYLNIDDCWIGGR | 71 | P17050 | |
| GAWEGTKAYGYTLDE | 4461 | P20929 |